Broadwood Capital INC 13F holdings
Broadwood Capital INC reported 6 positions with a total reported value of $1.9B as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: MNST MONSTER BEVERAGE CORP NEW (40.7%), STAA STAAR SURGICAL CO (24.2%), AXON AXON ENTERPRISE INC (20.3%), ISHARES TR (7.5%), IMDX INSIGHT MOLECULAR DIA INC (3.9%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Broadwood Capital INC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
6 largest of 6 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| MNST MONSTER BEVERAGE CORP NEW | 8,107,796 | $779.3M | 40.7% |
| STAA STAAR SURGICAL CO | 16,123,842 | $462.6M | 24.2% |
| AXON AXON ENTERPRISE INC | 693,504 | $388.8M | 20.3% |
| ISHARES TR | 474,920 | $142.7M | 7.5% |
| IMDX INSIGHT MOLECULAR DIA INC | 12,684,884 | $74.8M | 3.9% |
| LCTX LINEAGE CELL THERAPEUTICS IN | 49,560,992 | $64.9M | 3.4% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30
No new positions.
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| IMDX INSIGHT MOLECULAR DIA INC | 11,931,839 | 12,684,884 | +6.3% | $74.8M |
Decreases
No position was decreased.
CIK 1278387 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
